Abstract
Atrial septal defect and ventricular septal defect are the most common congenital heart diseases. These congenital defects produce a pulmonary blood flow overload with consequent risk of heart failure and pulmonary hypertension. Currently, various percutaneous occluder devices are available to achieve the closure, avoiding a surgical procedure. This chapter is introducing the features of the different occluder devices highlighting their advantages and disadvantages as well as the future perspective of biomedical engineering.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Soto B, Becker AE, Moulaert AJ, Lie JT, Anderson RH. Classification of ventricular septal defects. Br Heart J. 1980;43(3):332–43.
Donald DE, Edwards JE, Harshbarger HG, Kirklin JW. Surgical correction of ventricular septal defect: anatomic and technical considerations. J Thorac Surg. 1957;33(1):45–59.
Van Praagh R, Geva T, Kreutzer J. Ventricular septal defects: how shall we describe, name and classify them? J Am Coll Cardiol. 1989;14(5):1298–9.
Lopez L, Houyel L, Colan SD, Anderson RH, Béland MJ, Aiello VD, Bailliard F, Cohen MS, Jacobs JP, Kurosawa H, Sanders SP, Walters HL 3rd, Weinberg PM, Boris JR, Cook AC, Crucean A, Everett AD, Gaynor JW, Giroud J, Guleserian KJ, Hughes ML, Juraszek AL, Krogmann ON, Maruszewski BJ, St Louis JD, Seslar SP, Spicer DE, Srivastava S, Stellin G, Tchervenkov CI, Wang L, Franklin RCG. Classification of ventricular septal defects for the eleventh iteration of the international classification of diseases-striving for consensus: a report from the International Society for Nomenclature of Paediatric and congenital heart disease. Ann Thorac Surg. 2018;106(5):1578–89.
Agmon Y, Connolly HM, Olson LJ, Khandheria BK, Seward JB. Noncompaction of the ventricular myocardium. J Am Soc Echocardiogr. 1999;12(10):859–63.
Gerbode F, Hultgren H, Melrose D, Osborn J. Syndrome of left ventricular-right atrial shunt; successful surgical repair of defect in five cases, with observation of bradycardia on closure. Ann Surg. 1958;148(3):433–46.
Scott RC, McGuire J, Kaplan S, Fowler NO, Green RS, Gordon LZ, Shabetai R, Davolos DD. The syndrome of ventricular septal defect with aortic insufficiency. Am J Cardiol. 1958;2(5):530–53.
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139:e698–800.
Schubert S, Kelm M, Koneti NR, Berger F. First European experience of percutaneous closure of ventricular septal defects using a new CE-marked VSD occlude. EuroIntervention. 2019;15:e242–3.
Haponiuk I, Chojnicki M, Jaworski R, Steffek M, Juscinski J, Sroka M, Fiszer R, Sendrowska A, Gierat-Haponiuk K, Maruszewski B. Hybrid approach for closure of muscular ventricular septal defects. Med Sci Monit. 2013;19:618–24.
El-Sisi A, Sobhy R, Jaccoub V, Hamza H. Perimembranous ventricular septal defect device closure: choosing between Amplatzer duct Occluder I and II. Pediatr Cardiol. 2017;38(3):596–602.
Hua N, Aquino P, Owada CY. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer vascular plug-II. Cardiol Young. 2016;26(6):1194–201.
Chang H, Hung CR, Huang FY, Wu GJ. Hemolysis following correction of ventricular septal defect. J Formos Med Assoc. 1990;89(11):1004–8.
Hong ZN, Chen Q, Huang LQ, Cao H. A meta-analysis of perventricular device closure of perimembranous ventricular septal defect. J Cardiothorac Surg. 2019;14(1):119.
Anderson RH, Brown NA, Webb S. Development and structure of the atrial septum. Heart. 2002;88:104–10.
Raghib G, Ruttenberg HD, Anderson RC, et al. Termination of left superior vena cava in left atrium, atrial septal defect, and absence of coronary sinus; a developmental complex. Circulation. 1965;31:906–18.
Saxena A, Divekar A, Soni NR. Natural history of secundum atrial septal defect revisited in the era of transcatheter closure. Indian Heart J. 2005;57:35–8.
Cockerham JT, Martin TC, Gutierrez FR, et al. Spontaneous closure of secundum atrial septal defect in infants and young children. Am J Cardiol. 1983;52:1267–71.
Santoro G, Gaio G, Russo MG. Transcatheter treatment of unroofed coronary sinus. Catheter Cardiovasc Interv. 2013;81(5):849–52.
Butera G, Sturla F, Pluchinotta FR, Caimi A, Carminati M. Holographic augmented reality and 3D printing for advanced planning of sinus venosus ASD/partial anomalous pulmonary venous return percutaneous management. JACC Cardiovasc Interv. 2019;12(14):1389–91.
Mazic U, Gavora P, Masura J. The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder. Am Heart J. 2001;142:482–8.
Berger F, Ewert P, Abdul-Khaliq H, et al. Percutaneous closure of large atrial septal defects with the Amplatzer septal occluder: technical overkill or recommendable alternative treatment? J Interv Cardiol. 2001;14:63–7.
Varma C, Benson LN, Silversides C, et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Cathet Cardiovasc Interven. 2004;61:131–9.
Wahab HA, Bairam AR, Cao QL, Hijazi ZM. Novel technique to prevent prolapse of the Amplatzer septal occluder through large atrial septal defect. Cathet Cardiovasc Interven. 2003;60:543–5.
Dalvi BV, Pinto RJ, Gupta A. New technique for device closure of large atrial septal defects. Cathet Cardiovasc Interven. 2005;64:102–7.
Santoro G, Giordano M, Palladino MT, et al. ASD closure in special situations: elderly, PA-IVS. In: Butera G, Chessa M, Eicken A, Thomson J, editors. Atlas of cardiac catheterization for congenital heart disease. Cham: Springer; 2019.
Tufaro V, Butera G. Fenestrated ASD device “angioplasty”: how to adjust a "pop-off" mechanism when needed. Catheter Cardiovasc Interv. 2018;92(7):1329–33.
Mazic U, Gavora P, Masura J. “Cobra-like” deformation of an Amplatzer septal occluder. Pediatr Cardiol. 2001;22(3):253–4.
Butera G, Montinaro A, Carminati M. The “pull-push” technique to deal with a redundant Eustachian valve interfering with placement of a PFO occluder. Catheter Cardiovasc Interv. 2006;68:961–4.
McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects a case–control study. Circulation. 2016;133:1738–46.
Scognamiglio G, Barracano R, Colonna D, Mattera Iacono A, Santoro G, Spadafora A, Nappi G, Russo MG, Sarubbi B. A very late life-threatening complication after percutaneous closure of an atrial septal defect. Can J Cardiol. 2017;33(2):293.e1–2.
Qureshi AM, Mumtaz MA, Latson LA. Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation. Catheter Cardiovasc Interv. 2009;74(5):777–82.
Singh HR, Turner DR, Forbes TJ. Nickel allergy and the amplatzer septal occluder. J Invasive Cardiol. 2004;16(11):681–2.
Bissessor N. Current perspectives in percutaneous atrial septal defect closure devices. Med Dev (Auckl). 2015;8:297–303.
Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart. 2007;93:444–9.
Tang B, Su F, Sun X, Wu Q, Xing Q, Li S. Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders. J Biomed Mater Res B Appl Biomater. 2018;106(1):433–43.
Zhu YF, Huang XM, Cao J, Hu JQ, Bai Y, Jiang HB, Li ZF, Chen Y, Wang W, Qin YW, Zhao XX. Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol. 2012;2012:735989.
Shi D, Kang Y, Zhang G, Gao C, Lu W, Zou H, Jiang H. Biodegradable atrial septal defect occluders: a current review. Acta Biomater. 2019;96:68–80.
Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P, Spadoni I, Redaelli S, Hausdorf G. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Interv Cardiol. 2001;14(3):319–24.
Morgan G, Lee KJ, Chaturvedi R, Benson L. A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv. 2010;76(2):241–5.
Huang Y, Wong YS, Ng HCA, Boey FYC, Venkatraman S. Translation in cardiovascular stents and occluders: from biostable to fully degradable. Bioeng Transl Med. 2017;2(2):156–69.
Hoehn R, Hesse C, Ince H, Peuster M. First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease. Catheter Cardiovasc Interv. 2010;75(1):72–7.
Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol. 2006;48(1):161–9.
Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL, Jux C. BioSTAR evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation. 2006;114(18):1962–7.
Van den Branden BJ, Post MC, Plokker HW, ten Berg JM, Suttorp MJ. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up. JACC Cardiovasc Interv. 2010;3(9):968–73.
Pavcnik D, Tekulve K, Uchida BT, Luo ZH, Jeromel M, Van Alstine WG, Keller FS, Rösch J. Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects—a feasibility study in adult sheep. Radiol Oncol. 2012;46(2):89–96.
Sigler M, Söderberg B, Schmitt B, Mellmann A, Bernhard J. Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants. EuroIntervention. 2018;13(14):1655–61.
Sievert H, Söderberg B, Mellmann A, Bernhard J, Gafoor S, EuroIntervention first human use and intermediate follow-up of a septal occluder with a bioresorbable framework. EuroPCR, 2015; Paris.
Kenny DP, Hijazi ZM. Current status and future potential of transcatheter interventions in congenital heart disease. Circ Res. 2017;120(6):1015–26.
Duong-Hong D, Tang YD, Wu W, Venkatraman SS, Boey F, Lim J, Yip J. Fully biodegradable septal defect occluder-a double umbrella design. Catheter Cardiovasc Interv. 2010;76(5):711–8.
Huang Y, Wong YS, Wu J, Kong JF, Chan JN, Khanolkar L, Rao DP, Boey FY, Venkatraman SS. The mechanical behavior and biocompatibility of polymer blends for patent ductus arteriosus (PDA) occlusion device. J Mech Behav Biomed Mater. 2014;36:143–60.
Liu SJ, Peng KM, Hsiao CY, Liu KS, Chung HT, Chen JK. Novel biodegradable polycaprolactone occlusion device combining nanofibrous PLGA/collagen membrane for closure of atrial septal defect (ASD). Ann Biomed Eng. 2011;39(11):2759–66.
Xie ZF, Wang SS, Zhang ZW, Zhuang J, Liu XD, Chen XM, Zhang G, Zhang D. A novel-design poly-l-lactic acid biodegradable device for closure of atrial septal defect: long-term results in swine. Cardiology. 2016;135(3):179–87.
Li BN, Xie YM, Xie ZF, Chen XM, Zhang G, Zhang DY, Liu XD, Zhang ZW. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv. 2019;93(1):E38–45.
Wu W, Yip J, Tang YD, Khoo V, Kong JF, Duong-Hong D, Boey F, Venkatraman SS. A novel biodegradable septal defect occluder: the "Chinese lantern" design, proof of concept. Innovations (Phila). 2011;6(4):221–30.
Lu W, Ouyang W, Wang S, Liu Y, Zhang F, Wang W, Pan X. A novel totally biodegradable device for effective atrial septal defect closure: a 2-year study in sheep. J Interv Cardiol. 2018;31(6):841–8.
Zhu Y, Liu J, Wang L, Guan X, Luo Y, Geng J, Geng Q, Lin Y, Zhang L, Li X, Lu Y. Preliminary study of the application of transthoracic echocardiography-guided three-dimensional printing for the assessment of structural heart disease. Echocardiography. 2017;34(12):1903–8.
Huang XM, Zhu YF, Cao J, Hu JQ, Bai Y, Jiang HB, Li ZF, Chen Y, Wang W, Qin YW. Development and preclinical evaluation of a biodegradable ventricular septal defect occluder. Catheter Cardiovasc Interv. 2013;81(2):324–30.
Balk M, Behl M, Wischke C, Zotzmann J, Lendlein A. Recent advances in degradable lactide-based shape-memory polymers. Adv Drug Deliv Rev. 2016;107:136–52.
Cha KJ, Lih E, Choi J, Joung YK, Ahn DJ, Han DK. Shape-memory effect by specific biodegradable polymer blending for biomedical applications. Macromol Biosci. 2014;14(5):667–78.
Hardy JG, Palma M, Wind SJ, Biggs MJ. Responsive biomaterials: advances in materials based on shape-memory polymers. Adv Mater. 2016;28(27):5717–24.
Xu J, Song J. Polylactic acid (PLA)-based shape-memory materials for biomedical applications. In: Shape memory polymers for biomedical applications. Elsevier Ltd.; 2015. p. 197–217.
Zheng Y, Li Y, Hu X, Shen J, Guo S. Biocompatible shape memory blend for self-expandable stents with potential biomedical applications. ACS Appl Mater Interfaces. 2017;9(16):13988–98.
Jia H, Gu S-Y, Chang K. 3D printed self-expandable vascular stents from biodegradable shape memory polymer. Adv Polym Technol. 2018;37:3222–8.
Zarek M, Layani M, Cooperstein I, Sachyani E, Cohn D, Magdassi S. 3D printing of shape memory polymers for flexible electronic devices. Adv Mater. 2016;28(22):4449–54.
Noecker AM, Chen JF, Zhou Q, White RD, Kopcak MW, Arruda MJ, Duncan BW. Development of patient-specific three-dimensional pediatric cardiac models. ASAIO J. 2006;52(3):349–53.
Wang Z, Liu Y, Xu Y, Gao C, Chen Y, Luo H. Three-dimensional printing-guided percutaneous transcatheter closure of secundum atrial septal defect with rim deficiency: first-in-human series. Cardiol J. 2016;23(6):599–603.
Milano EG, Capelli C, Wray J, Biffi B, Layton S, Lee M, Caputo M, Taylor AM, Schievano S, Biglino G. Current and future applications of 3D printing in congenital cardiology and cardiac surgery. Br J Radiol. 2019;92(1094):20180389.
Olivieri LJ, Krieger A, Loke YH, Nath DS, Kim PC, Sable CA. Three-dimensional printing of intracardiac defects from three-dimensional echocardiographic images: feasibility and relative accuracy. J Am Soc Echocardiogr. 2015;28(4):392–7.
Kim MS, Hansgen AR, Wink O, Quaife RA, Carroll JD. Rapid prototyping: a new tool in understanding and treating structural heart disease. Circulation. 2008;117(18):2388–94.
He L, Cheng GS, Du YJ, Zhang YS. Feasibility of device closure for multiple atrial septal defects with an inferior sinus venosus defect: procedural planning using three-dimensional printed models. Heart Lung Circ. 2020;29(6):914–20.
Li P, Fang F, Qiu X, Xu N, Wang Y, Ouyang WB, Zhang FW, Hu HB, Pan XB. Personalized three-dimensional printing and echoguided procedure facilitate single device closure for multiple atrial septal defects. J Interv Cardiol. 2020;2020:1751025.
Velasco Forte MN, Byrne N, Valverde I, Gomez Ciriza G, Hermuzi A, Prachasilchai P, Mainzer G, Pushparajah K, Henningsson M, Hussain T, Qureshi S, Rosenthal E. Interventional correction of sinus venosus atrial septal defect and partial anomalous pulmonary venous drainage: procedural planning using 3D printed models. JACC Cardiovasc Imaging. 2018;11(2 Pt 1):275–8.
Yan C, Wang C, Pan X, Li S, Song H, Liu Q, Xu N, Wang J. Three-dimensional printing assisted transcatheter closure of atrial septal defect with deficient posterior-inferior rim. Catheter Cardiovasc Interv. 2018;92(7):1309–14.
Mashiko T, Otani K, Kawano R, Konno T, Kaneko N, Ito Y, Watanabe E. Development of three-dimensional hollow elastic model for cerebral aneurysm clipping simulation enabling rapid and low cost prototyping. World Neurosurg. 2015;83(3):351–61.
Schmauss D, Haeberle S, Hagl C, Sodian R. Three-dimensional printing in cardiac surgery and interventional cardiology: a single-Centre experience. Eur J Cardiothorac Surg. 2015;47(6):1044–52.
Hunter KS, Lanning CJ, Chen SY, Zhang Y, Garg R, Ivy DD, Shandas R. Simulations of congenital septal defect closure and reactivity testing in patient-specific models of the pediatric pulmonary vasculature: a 3D numerical study with fluid-structure interaction. J Biomech Eng. 2006;128(4):564–72.
Rigatelli G, Zuin M, Fong A. Computational flow dynamic analysis of right and left atria in patent foramen Ovale: potential links with atrial fibrillation. J Atr Fibrillation. 2018;10(5):1852.
Lee W, Jung E. A multiscale model of cardiovascular system including an immersed whole heart in the cases of normal and ventricular septal defect (VSD). Bull Math Biol. 2015;77(7):1349–76.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Giordano, M., Bosi, G., Butera, G. (2022). Septal Defects: Clinical Concepts, Engineering Applications, and Impact of an Integrated Medico-Engineering Approach: Occluder Devices. In: Butera, G., Schievano, S., Biglino, G., McElhinney, D.B. (eds) Modelling Congenital Heart Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-88892-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-88892-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-88891-6
Online ISBN: 978-3-030-88892-3
eBook Packages: MedicineMedicine (R0)